XVIVO: High organic growth and distinct economies of scale - Redeye

Q4 is another solid quarter with 44% organic growth (CER), 6-7% above expectations. The main growth driver is disposables, where Thoracic, XVIVO’s largest business unit, delivered 50% organic growth and improved gross margins to 87%.

Länk till analysen i sin helhet: https://www.redeye.se/research/1069532/xvivo-high-organic-growth-and-distinct-economies-of-scale?utm_source=finwire&utm_medium=RSS